MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bascands, J. L.
Right arrow Articles by Girolami, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bascands, J. L.
Right arrow Articles by Girolami, J. P.

Indirect inhibition by bradykinin of cyclic AMP generation in isolated rat glomeruli and mesangial cells

JL Bascands, C Pecher and JP Girolami

Institute National de la Sante et de la Recherche Medicale (CJF 92.05), Institut Louis Bugnard, School of Medicine Rangueil, Toulouse, France.

The present study was designed to evaluate the effect of the activation of bradykinin (BK) receptors on intracellular cAMP levels in isolated glomeruli as well as in cultured rat mesangial cells. BK affected basal cAMP content only in the presence of the phosphodiesterase inhibitor isobutylmethylxanthine. Furthermore, BK inhibited forskolin-, prostaglandin E2-, and isoproterenol-stimulated cAMP accumulation, both in the presence and in the absence of isobutylmethylxanthine. The inhibitory effect of BK was independent of stimulation of cAMP degradation by phosphodiesterase. No direct inhibition of the in vitro adenylyl cyclase activity was observed, suggesting a requirement for cytoplasmic constituents. Use of the phospholipase A2 inhibitor mepacrine and treatment with pertussis toxin did not modify the inhibitory effect of BK, indicating that neither the phospholipase A2 pathway nor the inhibitory G protein is involved. The effect of BK was completely prevented by two selective protein kinase C (PKC) inhibitors, staurosporine and bisindolylmaleimide. Furthermore, use of the diacylglycerol analog 1-oleoyl-2-acetyl-rac-glycerol and direct activation of PKC with phorbol-12-myristate-13-acetate mimicked the effect of BK, whereas the biologically inactive phorbol ester 4 alpha- phorbol-12, 13-didecanoate was without effect. Furthermore, down- regulation of PKC by long term pretreatment with phorbol-12-myristate- 13-acetate abolished the inhibitory effect of BK on stimulated cAMP levels. These results demonstrate that BK inhibits forskolin-, prostaglandin E2-, and isoproterenol-stimulated cAMP formation through activation of the phospholipase C pathway. The subsequent production of diacylglycerol associated with stimulation of PKC in turn inhibits stimulated cAMP accumulation.

Volume 44, Issue 4, pp. 818-826, 10/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
M. E. M. Castano, J. P. Schanstra, C. Hirtz, J. B. Pesquero, C. Pecher, J.-P. Girolami, and J.-L. Bascands
B2 kinin receptor upregulation by cAMP is associated with BK-induced PGE2 production in rat mesangial cells
Am J Physiol Renal Physiol, March 1, 1998; 274(3): F532 - F540.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics